These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12750027)

  • 1. Impact of the aryl substituent kind and distance from pyrimido[2,1-f]purindiones on the adenosine receptor selectivity and antagonistic properties.
    Drabczyńska A; Schumacher B; Müller CE; Karolak-Wojciechowska J; Michalak B; Pekala E; Kieć-Kononowicz K
    Eur J Med Chem; 2003 Apr; 38(4):397-402. PubMed ID: 12750027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors.
    Kim YC; Ji X; Melman N; Linden J; Jacobson KA
    J Med Chem; 2000 Mar; 43(6):1165-72. PubMed ID: 10737749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N9-benzyl-substituted 1,3-dimethyl- and 1,3-dipropyl-pyrimido[2,1-f]purinediones: synthesis and structure-activity relationships at adenosine A1 and A2A receptors.
    Drabczyńska A; Müller CE; Karolak-Wojciechowska J; Schumacher B; Schiedel A; Yuzlenko O; Kieć-Kononowicz K
    Bioorg Med Chem; 2007 Jul; 15(14):5003-17. PubMed ID: 17499511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adenosine A(2A) antagonistic properties of selected C8-substituted xanthines.
    Van der Walt MM; Terre'Blanche G; Petzer A; Lourens AC; Petzer JP
    Bioorg Chem; 2013 Aug; 49():49-58. PubMed ID: 23892098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships in a series of 8-substituted xanthines as A1-adenosine receptor antagonists.
    Strappaghetti G; Corsano S; Barbaro R; Giannaccini G; Betti L
    Bioorg Med Chem; 2001 Mar; 9(3):575-83. PubMed ID: 11310591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases.
    Koch P; Akkari R; Brunschweiger A; Borrmann T; Schlenk M; Küppers P; Köse M; Radjainia H; Hockemeyer J; Drabczyńska A; Kieć-Kononowicz K; Müller CE
    Bioorg Med Chem; 2013 Dec; 21(23):7435-52. PubMed ID: 24139167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenylethyl-substituted pyrimido[2,1-f]purinediones and related compounds: structure-activity relationships as adenosine A(1) and A(2A) receptor ligands.
    Drabczyńska A; Müller CE; Schiedel A; Schumacher B; Karolak-Wojciechowska J; Fruziński A; Zobnina W; Yuzlenko O; Kieć-Kononowicz K
    Bioorg Med Chem; 2007 Nov; 15(22):6956-74. PubMed ID: 17827019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological activity of tricyclic aryloimidazo-, pyrimido-, and diazepinopurinediones.
    Drabczyńska A; Müller CE; Lacher SK; Schumacher B; Karolak-Wojciechowska J; Nasal A; Kawczak P; Yuzlenko O; Pekala E; Kieć-Kononowicz K
    Bioorg Med Chem; 2006 Nov; 14(21):7258-81. PubMed ID: 16844379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imidazo[2,1-i]purin-5-ones and related tricyclic water-soluble purine derivatives: potent A(2A)- and A(3)-adenosine receptor antagonists.
    Müller CE; Thorand M; Qurishi R; Diekmann M; Jacobson KA; Padgett WL; Daly JW
    J Med Chem; 2002 Aug; 45(16):3440-50. PubMed ID: 12139454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent developments in the field of A2A and A3 adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Bovero A; Avitabile B; Preti D; Fruttarolo F; Romagnoli R; Varani K; Borea PA
    Eur J Med Chem; 2003 Apr; 38(4):367-82. PubMed ID: 12750024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 8-Azaxanthine derivatives as antagonists of adenosine receptors.
    Franchetti P; Messini L; Cappellacci L; Grifantini M; Lucacchini A; Martini C; Senatore G
    J Med Chem; 1994 Sep; 37(18):2970-5. PubMed ID: 8071944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
    Hayallah AM; Sandoval-Ramírez J; Reith U; Schobert U; Preiss B; Schumacher B; Daly JW; Müller CE
    J Med Chem; 2002 Mar; 45(7):1500-10. PubMed ID: 11906291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7-Deazaadenines bearing polar substituents: structure-activity relationships of new A(1) and A(3) adenosine receptor antagonists.
    Hess S; Müller CE; Frobenius W; Reith U; Klotz KN; Eger K
    J Med Chem; 2000 Nov; 43(24):4636-46. PubMed ID: 11101355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorosulfonyl-substituted xanthines as selective irreversible antagonists for the A(1)-adenosine receptor.
    Beauglehole AR; Baker SP; Scammells PJ
    J Med Chem; 2000 Dec; 43(26):4973-80. PubMed ID: 11150167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacological evaluation of novel 1- and 8-substituted-3-furfuryl xanthines as adenosine receptor antagonists.
    Balo MC; Brea J; Caamaño O; Fernández F; García-Mera X; López C; Loza MI; Nieto MI; Rodríguez-Borges JE
    Bioorg Med Chem; 2009 Sep; 17(18):6755-60. PubMed ID: 19682912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of trifluoromethyl and other substituents on activity of xanthines at adenosine receptors.
    Jacobson KA; Shi D; Gallo-Rodriguez C; Manning M; Müller C; Daly JW; Neumeyer JL; Kiriasis L; Pfleiderer W
    J Med Chem; 1993 Sep; 36(18):2639-44. PubMed ID: 8410976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 8-Substituted 1,3-dimethyltetrahydropyrazino[2,1-f]purinediones: Water-soluble adenosine receptor antagonists and monoamine oxidase B inhibitors.
    Brunschweiger A; Koch P; Schlenk M; Rafehi M; Radjainia H; Küppers P; Hinz S; Pineda F; Wiese M; Hockemeyer J; Heer J; Denonne F; Müller CE
    Bioorg Med Chem; 2016 Nov; 24(21):5462-5480. PubMed ID: 27658798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8-(Sulfostyryl)xanthines: water-soluble A2A-selective adenosine receptor antagonists.
    Müller CE; Sandoval-Ramírez J; Schobert U; Geis U; Frobenius W; Klotz KN
    Bioorg Med Chem; 1998 Jun; 6(6):707-19. PubMed ID: 9681137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological evaluation of novel 1,3,8- and 1,3,7,8-substituted xanthines as adenosine receptor antagonists.
    Rodríguez-Borges JE; García-Mera X; Balo MC; Brea J; Caamaño O; Fernández F; López C; Loza MI; Nieto MI
    Bioorg Med Chem; 2010 Mar; 18(5):2001-9. PubMed ID: 20137957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.